home / stock / acst:cc / acst:cc short
Short Information | Acasti Pharma Inc. (TSXVC:ACST:CC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 0 |
Total Actual Volume | 0 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 0 |
Average Short Percentage | 0.00% |
Is there a ACST:CC Short Squeeze or Breakout about to happen?
See the ACST:CC Short Analysis for free Sign up or Login
Powered by Squeeze Report
News, Short Squeeze, Breakout and More Instantly...
Acasti Pharma Inc. Company Name:
ACST:CC Stock Symbol:
TSXVC Market:
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application (NDA) Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, On Track for NDA Submission Timeline Poster Highlighting the STRIVE-ON...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (...
PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel intravenous formulation of nimodipine being developed to address the high unmet medical needs for a rare disease, aneurysmal S...